Zacks
Hims & Hers Expands Platform-Led Access to Digital Healthcare
📈
AI Sentiment
Highly Positive
8/10
- Home
- AMWL
as of 01-20-2026 11:24am EST
$4.58
$0.18
-3.78%
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | Boston |
| Market Cap: | 111.4M | IPO Year: | 2020 |
| Target Price: | $7.58 | AVG Volume (30 days): | 88.7K |
| Analyst Decision: | Hold | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.18 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.71 - $12.95 | Next Earning Date: | 02-11-2026 |
| Revenue: | $265,023,000 | Revenue Growth: | 4.33% |
| Revenue Growth (this year): | -1.08% | Revenue Growth (next year): | -2.54% |
AI-Powered AMWL Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 20 hours ago
AI Recommendation
hold
Model Accuracy: 0.00%
0.00%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of American Well Corporation (AMWL)
McNeice Paul Francis
Sell
Chief Accounting Officer
AMWL Jan 2, 2026
Avg Cost/Share
$4.85
Shares
384
Total Value
$1,862.40
Owned After
3,063
SEC Form 4
Gotlib Phyllis
Sell
President, International
AMWL Jan 2, 2026
Avg Cost/Share
$4.85
Shares
3,707
Total Value
$17,978.95
Owned After
119,870
SEC Form 4
Zamansky Dmitry
Sell
Chief Product & Tech. Officer
AMWL Jan 2, 2026
Avg Cost/Share
$4.85
Shares
6,243
Total Value
$30,278.55
Owned After
191,468
SEC Form 4
Jackson Deborah C
Sell
Director
AMWL Dec 18, 2025
Avg Cost/Share
$4.73
Shares
612
Total Value
$2,883.00
Owned After
0
McNeice Paul Francis
Sell
Chief Accounting Officer
AMWL Dec 1, 2025
Avg Cost/Share
$4.06
Shares
113
Total Value
$458.47
Owned After
3,063
SEC Form 4
Gotlib Phyllis
Sell
President, International
AMWL Dec 1, 2025
Avg Cost/Share
$4.06
Shares
3,574
Total Value
$14,500.79
Owned After
119,870
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| McNeice Paul Francis | AMWL | Chief Accounting Officer | Jan 2, 2026 | Sell | $4.85 | 384 | $1,862.40 | 3,063 | |
| Gotlib Phyllis | AMWL | President, International | Jan 2, 2026 | Sell | $4.85 | 3,707 | $17,978.95 | 119,870 | |
| Zamansky Dmitry | AMWL | Chief Product & Tech. Officer | Jan 2, 2026 | Sell | $4.85 | 6,243 | $30,278.55 | 191,468 | |
| Jackson Deborah C | AMWL | Director | Dec 18, 2025 | Sell | $4.73 | 612 | $2,883.00 | 0 | |
| McNeice Paul Francis | AMWL | Chief Accounting Officer | Dec 1, 2025 | Sell | $4.06 | 113 | $458.47 | 3,063 | |
| Gotlib Phyllis | AMWL | President, International | Dec 1, 2025 | Sell | $4.06 | 3,574 | $14,500.79 | 119,870 |
Latest American Well Corporation News
AMWL Breaking Stock News: Dive into AMWL Ticker-Specific Updates for Smart Investing
Compare AMWL vs Leading Stocks
See how AMWL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "AMWL American Well Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.